Open AccessAn Analysis of Quality Improvement Education at US Colleges of Pharmacy
Author(s) -
Janet Cooley,
Samuel F. Stolpe,
Amber Montoya,
Angela Walsh,
Ana L. Hincapie,
Vibhuti Arya,
Melissa Nelson,
Terri Warholak
Publication year - 2017
Publication title -
american journal of pharmaceutical education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.796
H-Index - 63
eISSN - 1553-6467
pISSN - 0002-9459
DOI - 10.5688/ajpe81351
Subject(s) - curriculum , pharmacy , accreditation , medical education , medicine , quality (philosophy) , quality management , payment , incentive , family medicine , pharmacy education , pharmacy school , pharmacy practice , psychology , business , pedagogy , engineering , operations management , management system , philosophy , epistemology , finance , economics , microeconomics
Objective. Analyze quality improvement (QI) education across US pharmacy programs. Methods. This was a two stage cross-sectional study that inspected each accredited school website for published QI curriculum or related content, and e-mailed a questionnaire to each school asking about QI curriculum or content. T-test and chi square were used for analysis with an alpha a priori set at .05. Results. Sixty responses (47% response rate) revealed the least-covered QI topics: quality dashboards /sentinel systems (30%); six-sigma or other QI methodologies (45%); safety and quality measures (57%); Medicare Star measures and payment incentives (58%); and how to implement changes to improve quality (60%). More private institutions covered Adverse Drug Events than public institutions and required a dedicated QI class; however, required QI projects were more often reported by public institutions. Conclusion. Despite the need for pharmacists to understand QI, it is not covered well in school curricula
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom